Logan Rodgers
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Eli Lilly (United States) (2026)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Logan Rodgers' research investigates the characteristics of KRASG12C inhibitors, specifically olomorasib, in single-agent and combination therapies. This work focuses on models with KRASG12C mutations, exploring their potential in cancer treatment. Rodgers has also contributed to studies examining the effects of environmental changes on physical activity, using playground renovation as a natural experiment. This latter work appears in "A Year Of Recess Observations: A Natural Experiment Of Playground Renovation Effects On Physical Activity" (2026), while the former is detailed in "Characterization of KRASG12C inhibitor olomorasib single-agent and combination with activity in KRASG12C-mutant models" (2026). Rodgers' scholarship metrics indicate a total of two publications, with recent activity noted in 2026.
Metrics
- Publications: 2
Selected Publications
-
A Year Of Recess Observations: A Natural Experiment Of Playground Renovation Effects On Physical Activity (2026)
Collaboration Network
Top Collaborators
- A Year Of Recess Observations: A Natural Experiment Of Playground Renovation Effects On Physical Activity
- A Year Of Recess Observations: A Natural Experiment Of Playground Renovation Effects On Physical Activity
- A Year Of Recess Observations: A Natural Experiment Of Playground Renovation Effects On Physical Activity
Similar Researchers
Based on overlapping research topics